













































































































































































































































Low elasticity of thyroid nodules on ultrasound elastography is correlated with 
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Disclosure Statment: the authors have nothing to disclose 
Abstract 
Background: Thyroid ultrasound elastography (US elastography) provides an estimation of 
tissue stiffness and is helpful to differentiate malignant from benign lesions. Tissue 
proprieties and molecules causing stiffness are not established. The aim of the study was to 
correlate US elastography findings with tissue properties in thyroid nodules. 
Methods. 115 thyroid nodules from 112 patients who underwent surgery for the presence of 
of Thy 3 (indeterminate) cytology (n=67), Thy 4-5 (suspicious-indicative of carcinoma) 
cytology (n= 47) or large goiter in the presence of Thy 2 cytology (n= 1) and suspicious US 
features were examined by US elastography. Tissues obtained after surgery were 
characterized for cell number, microvessel density, fibrosis, expression of galectin-3 (Gal-3) 
and fibronectin-1(FN-1). 
Results: Low elasticity on qualitative US elastography (LoEl) was found in 66 nodules, 1 
benign and 65 carcinomas, high elasticity (HiEl) in 49 nodules, 46 benign and 3 carcinomas 
(p<0.0001). Quantitative analysis, performed in 24 nodules and expressed as elastic ratio 
between the strain of the nodule and that of the surrounding thyroid parenchyma,  was 1.90 
(1.18-2.77) (median and IQR) in 14 nodules with LoEl and 1.01-(0.91-1.10) in 10 nodules 
with HiEl (p=0.002). Stiffness did not correlate with cell number and was inversely 
correlated with microvessel density. Fibrosis was higher in nodules with LoEl than in those 
with HiEl (p=0.009) and in carcinomas than in benign nodules (p=0.02). Fibrosis was higher 
in nodules with high expression of Gal-3 (p<0.001) and FN-1 (p=0.004). Fibrosis and 



























































































































































































































































































































































































































expression of Gal-3 and FN-1 were higher in the classic vs the follicular variant of papillary 
thyroid carcinoma and lower in follicular adenomas. 
Conclusions: i) Low elasticity at US elastography is highly correlated with malignancy; ii) 
nodule stiffness is correlated with fibrosis and expression of Gal-3 and FN-1; iii) these 














































































































































































































































































































































































































































Nodular thyroid disease is a common finding in the general population, in particular in iodine 
deficient areas. Thyroid nodules are palpable in 5% of subjects (1,2 ), but are detectable by 
thyroid ultrasound in up to 50% of the general  population (3-4). 
Cytological examination of material obtained by fine needle aspiration (FNA), due to its high 
sensitivity and specificity, is the best single test for differentiating malignant from benign 
thyroid lesions (5). The major limitations of FNA cytology are the occurrence of 
nondiagnostic (10-15%) and indeterminate (10-20 %) cytology (6-7).  
The newly developed ultrasound elastography (US elastography) has been applied to study 
the stiffness/elasticity of nodules, with the purpose of differentiating malignant from benign 
lesions. As for thyroid cancer, a low elasticity on US elastography showed a high predictive 
value in the assessment of malignancy (8-9). The reliability of US elastography was 
confirmed by several authors and recently reviewed in a meta-analysis (10). Interestingly, US   
elastography maintains its high predictive value in thyroid nodules with indeterminate 
cytology in our (11) and other series (12-16). Hence, US elastography can be considered an 
additional diagnostic tool for the management of indeterminate thyroid lesions (2-3). The 
results obtained with real time US elastography were confirmed by quantitative elastographic  
techniques, such as strain index, acoustic radiation force impulse and supersonic shear wave 
(17-18).  



























































































































































































































































































































































































































The tissue proprieties that link stiffness to cancer in thyroid nodules are unknown. 
Theoretically, an increased cell number and/or fibrosis could account for nodule stiffness. An 
increased expression of molecules involved in cell to cell and cell to matrix adhesion as well 
as in fibrosis has been described in thyroid neoplasia. In addition, some of them, such as Gal-
3 (19-23) and HBME-1 (24-26) have also been employed as cytochemical tumor markers. To 
validate real-time US elastography as a robust new technique for the assessment of 
malignancy in thyroid nodules we decided to compare real time qualitative with quantitative 
US elastography in a series of patients and to analyze tissue proprieties in surgical samples 
that could correlate with nodule stiffness such as cell number, microvessel density, degree of 
fibrosis and expression of Gal-3 and FN-1. 
Patients and Methods 
Patients 
In the period January to March  2012  patients with 1 or 2 nodules in the absence of 
confounding factors such as thyroiditis, multinodularity with coalescent nodules and 
macrocalcifications underwent US elastography. Among them 112 patients (mean age 44 + 
13 yr; range 8-74; 78 females and 34 males)  in whom surgery was indicated for Thy 3 
cytology (n=67), Thy 4-5 cytology (n= 47) or large goiter in the presence of Thy 2 cytology 
(n= 1) and suspicious US features (1,2) were selected for this study. Three patients had two 
nodules with Thy 3 cytology. Thus, a total of 115 nodules were included in the study. 
Nodular volume (mean +SD) was 4.6 + 9.76 ml. Patients gave their consent to participate in 
the study allowing molecular analysis of biological material. All patients were euthyroid in 
the absence of circulating thyroid autoantibodies and had undetectable serum calcitonin 



























































































































































































































































































































































































































measured with immunoradiometric assay (CIS BIO International, France, normal values <10 
ng/mL). 
Fine needle aspiration cytology 
FNA was performed under US guidance using a 23 gauge needle attached to a 10 mL 
syringe. The material was air-dried, stained with Papanicolaou and Giemsa and interpreted by 
two experienced cytologists (DG, MI). The adequacy of aspirates was defined according to 
the guidelines of the Papanicolaou Society (27). Results of cytology were reported according 
to the Italian Consensus (28).  
Histological diagnosis and morphological features 
Histological diagnoses were made with standard procedure (hematoxylin/eosin), 
according to the WHO 2004 system (29) and confirmed independently, in a blinded fashion 
by three pathologists (A.P., L.T., and F.B.). Tumor fibrosis was expressed as the percentage 
of dense connective tissue with respect to the tumor cell-occupied area in the whole nodule (2 
to 5 slides) and expressed both as mean value ± SD and median with interquartile range 
(IQR). To evalutate the number of cells, the slides were observed under a standard Nikon 
TS100F microscope (Nikon Instruments, Florence, Italy) connected to a digital video system. 
Using a 40×magnification lens, three fields representative of the whole nodule were sampled 
randomly and photographed using an MMI GmbH digital microphotography system (Nikon 
Instruments). Cells were counted by an image analysis using the Nis Elements AR software 
(Nikon Instruments) and reported as mean ± SD.  
To evaluate tumor microvessel density, tissue sections were immunostained with an anti-
CD34 primary antibody using an automated Benchmark IHC staining system (Ventana, 



























































































































































































































































































































































































































Tucson, Arizona, USA). The immunostained slides were observed under a 40x magnification 
lens with a standard microscope connected to a digital video system, as described above. 
Three representative fields with the highest vascularity were chosen for each sample and 
photographed as previously described. Results were reported as the area occupied by the 
microvessel (μm2/field, mean value ± SD). AP, FB, LT who performed cytology, pathology, 
and evaluation of cell number, microvessel density and fibrosis were unaware of the US   
elastography data. 
RNA purification and complementary DNA synthesis 
After standard deparaffinization, formalin-fixed and paraffin-embedded (FFPE) 
thyroid tissue sections (5 μm) were enriched by manual microdissection. Then, RNA was 
extracted and purified from the FFPE tissue sections using the Qiagen RNeasy FFPE kit 
(GmbH, Hilden, Germany). RNA integrity was assessed by spectrophotometry (NanoDrop 
ND-1000 Technologies, Wilmington, DE, USA). 
Semiquantitative real-time reverse-transcription polymerase chain reaction (PCR) 
Gal-3 and FN-1 mRNA quantification was performed using the real time quantitative 
PCR Rotor Gene Sybr Green PCR kit (Qiagen) on a Rotor Gene 6000 (Qiagen) instrument. 
Quanti tect primer assays (Qiagen) were used for Gal-3 (NM_001177388, NM_002306, 
NM_194327), FN-1 (NM_002026, NM_212474, NM_212475, NM_212476, NM_212478, 
NM_212482) and beta-actin (NM_001101) as an internal control. Pooled normal thyroid 
tissues were used as external control. The comparative threshold cycle (Ct) method, defined 
as 2
-ΔΔCt
, was used for calculation of fold amplification of each sample versus external 
control. Each experiment was evaluated with three PCR reactions. Data are presented as the 
mean value ± SD. Gal-3 and FN-1 mRNA expression of each sample was normalized by 



























































































































































































































































































































































































































calculating the z score obtained by subtracting the population mean and dividing by the 
standard deviation. The converted z scores were then aggregated into one large set, 
identifying two different categories: ‘low expression’ (negative z score) and ‘high 
expression’ (positive z score). RG, NB, who measured expression of FN-1 and Gal-3 were 
unaware of the US elastography data as well as the cytology and pathology data. 
 
Thyroid US elastography 
Thyroid US elastography was performed using a real-time instrument (Esaote SPA, 
My Lab 70) with a linear transducer (8-13 MHz). The qualitative analysis of US   
elastography was performed using the methodology previously described (9,11). In nodules 
with high elasticity (HiEl) the green color was clearly dominant and classified as likely 
benign; in nodules with intermediate elasticity the pattern of color distribution was 
inhomogeneous with both green and blue color represented and classified as suspicious. In 
nodules with very low elasticity the blue color was clearly predominant and classified as 
likely malignant. Nodules with intermediate and low elasticity were grouped and classified as 
nodules with low elasticity (LoEl).  
For the quantitative analysis the operator used had an electronic box, which included 
the selected nodule and an adequate amount of surrounding parenchyma. Two regions of 
interest, one corresponding to the nodule and one to the softest area of normal parenchyma 
were identified on elastogram. The elastic ratio (ER) between the strain of the nodule and the 
surrounding thyroid parenchyma was calculated automatically by the software (30). During 
the study ER, became available and we decided, as a secondary endpoint,  to compare the 
results of the two techniques. Unfortunately, the majority of patients had already been 



























































































































































































































































































































































































































surgically treated and only 24 nodules were available for this comparison. US  elastography 
was performed by TR, MS ad VL before FNA. In vivo examination was performed by 2 
examiners. Static and moving images were also recorded to be reviewed by the third 
examiner. The agreement on the US  elastography scoring among the three examiners was > 
90%. 
Statistical analysis  
Proportions and frequencies in the group of patients were compared using the χ2 test and 
the Fischer exact test, when appropriate. The Kolmogorov-Smirnov test was employed to 
test the normality of data distribution. Student’s t-test and Mann-Whitney U test were US   
elastography had to detect difference between groups for normal and skewed variables, 
respectively. A p-value less than or equal to 0.05 was considered statistically significant. 
Statistical analyses were performed using the SPSS for Windows 10.0 computer software 
(SPSS Inc., Chicago, IL). ROC curve analyses were performed to identify the ER cut-off that 
better discriminated between carcinomas and benign nodules in term of sensitivity and specificity 
(i.e., highest Youden index). 
 
Results 
1. Cytology and  Histology 
Among the 67 nodules with Thy 3 cytology, 20 (31%) were papillary carcinomas on 
histology (14 follicular variant, 6 classic variant) and 1 was a minimally invasive follicular 
thyroid carcinoma. The remaining 46 (69%) were benign: 37 were follicular adenomas, 2 



























































































































































































































































































































































































































hyperplastic nodules and 7 follicular adenomas with foci (<5 mm) of papillary carcinoma 
(Table 1). 
Among the 47 nodules with Thy 4-5 cytology, 46 (98%) were papillary thyroid carcinomas 
(29 classic variant, 10 follicular variant  and 7 tall cell variant); 1 nodule was hyperplastic.  
The large nodule with Thy 2 cytology was a follicular variant of papillary carcinoma on 
histology (Table 1). 
2. US  elastography   
HiEl at real time US elastography was found in 49 cases, 46 benign lesions  and 3 
carcinomas; LoEl was observed in 66 cases, 65 carcinomas and one benign nodule  (Fig. 1). 
Thus, low elasticity was highly predictive of malignancy (p<0.0001). The ER was 1.90 (1.18-
2.77) (median and IQR) in 14 nodules with LoEl and 1.01-(0.91-1.10) in 10 nodules with 
HiEl (p=0.002). The ER cut-off of 1.1 identified carcinomas with a sensitivity of 86 % 
(12/14) and benign nodules with a specificity of 90% (9/10), the negative predictive value 
was 82%, the positive predictive value 92% (Fig. 2). 
3. Correlation between US elastography and cellularity, microvessel density, degree of 
fibrosis and expression of Gal-3 and FN-1 
Cell number did not correlate with elasticity: 334 (289-408) (median and IQR) 
cells/field in nodules with HiEl and 308.5 (255-366.5) cells/field in nodules with LoEl 
(p=0.12). On the other hand, microvessel density inversely correlated with elasticity: 168.2 
(125.7-217) μm2/field (median and IQR) in nodules with HiEl and 108.6 (92.4-158.5) 
μm2/field in those with LoEl (p<0.001).  
The degree of fibrosis inversely correlated with elasticity: 5 (0-10) (median and IQR) in 
nodules with HiEl and 10 (0-30) in nodules with LoEl (p=0.009).  



























































































































































































































































































































































































































Among the 49 nodules with HiEl, 2 had high and 47 low expression of Gal-3, while out of 
the 66 nodules with LoEl, 37 had high and 29 low expression of Gal-3 (p<0.001). All the 49 
nodules with HiEl had low expression of FN-1, while of the 66 nodules with LoEl 27 had 
high and 39 low expression of FN-1 (p<0.001) (Table 2). Thus, with regard to the finding of 
LoEl,  low expression of Gal-3 had a negative predictive value (NPV) of 95.9%, while high 
expression of Gal-3 had a positive predictive value (PPV) of 94.8 %. Low expression of 
FN-1 had a NPV of 100%, while high expression  of FN-1 had a PPV of 40.9%. 
 
4. Correlation between histology and cellularity, microvessel density, degree of fibrosis and 
expression of Gal-3 and FN-1 
While cell number did not differ between benign nodules (333.5 [284-408] 
cells/field), (median and IQR) (p=0.15) and carcinomas (309 [256-371] cells/field), 
microvessel density was higher in benign nodules (173.1 [129-223.6] μm2/field), (median and 
IQR) than in carcinomas (108.8 [92.4-157.6] μm2/field), (p<0.001). The degree of fibrosis 
was higher in carcinomas 10 (0-30) (median and IQR) than in nodules with benign histology 
5 (0-10) (p=0.02). Among the 47 benign nodules,1 had high and 46 low expression of Gal-3, 
while out of the 68 carcinomas 38 had high and 30 low expression of Gal-3, (p<0.001). All 
the 47 benign nodules had low expression of FN-1, while among 68 carcinomas, 27 had high 
and 41 low expression of FN-1 (p<0.001) (Table 3). Fibrosis was 20 (3-40) (median and 
IQR) in nodules with high expression of Gal-3, and 5 (0-10) in those with low expression of 
Gal-3 (p<0.001). Fibrosis was 20 (3-40) in nodules with high expression of FN-1, and 5 (0-
12.5) in those with low expression of FN-1 (p=0.004) (data not shown).Thus, with regard to 
the histological diagnosis of carcinoma, low expression of Gal-3 had a NPV of 97.8%, while 



























































































































































































































































































































































































































high expression of Gal-3 had  a PPV of 55.8 %.  Low expression of FN-1 had a NPV of 
100%, while high expression of FN-1 had  a PPV of 39.7%. 
 
5. US elastography, cellularity, microvessel density and degree of fibrosis in the classic and 
the follicular variant of papillary thyroid carcinoma and  in follicular adenoma 
Out of the 35 classic variant of papillary thyroid carcinoma, 1 had HiEl, and 34 had 
LoEl, while out of the 25 follicular variant, 2 had HiEl and 23 LoEl (p<0.001). In contrast, all 
the 37 follicular adenomas had HiEl. Cell number was 334 (289-408) cells/field, (median and 
IQR) in follicular adenomas, 336 (244-474) in the follicular variant of papillary thyroid 
carcinoma, 309 (256-349) in the classic variant (p=0.15). The microvessel density was 182.5 
(148.7-230.2) μm2/field (median and IQR) in follicular adenomas, 115.5 (92.4-200.4) 
μm2/field  in the follicular variant of papillary thyroid carcinoma, and 107.7 (92.6-105.5) 
μm2/field in the classic variant (p=0.001). The degree of fibrosis was 5 (0-10) (median and 
IQR) in follicular adenomas, 5 (0-20)
 
in the follicular variant, and 17.5 (2-30) in the classic 
variant of papillary carcinoma (p=0.01). In addition, high expression of both Gal-3 and FN-1 
was found more often in the classic variant than in the follicular variant of papillary thyroid 
carcinomas and almost never in the follicular adenomas with only 1 out of 37 showing high 
expression of Gal-3 (Table 4). 
Discussion 
Real time US elastography has been shown to be a useful diagnostic tool in the 
management of thyroid nodules, with high elasticity having a high negative predictive value 
for thyroid carcinoma even in indeterminate nodules (9,11). The results obtained by real time   



























































































































































































































































































































































































































elastography were confirmed by methods providing an objective measurement of tissue 
stiffness such as strain index, acoustic radiation force impulse and supersonic shear wave (17-
18). 
The aim of this study was to compare the qualitative real time with quantitative US   
elastography and correlate US elastography findings with tissue properties associated with 
stiffness/elasticity of thyroid nodules. An optimal correlation between nodule stiffness and 
thyroid cancer was confirmed. The elasticity was measured both by qualitative real time and 
quantitative US elastography and data obtained by the two methods were highly correlated, 
thus validating the qualitative measurements and strengthening the value of this technique. 
The reason why tissue stiffness is correlated with malignancy is  unknown. We hypothesized 
that the number of cells, the microvessel density and the degree of fibrosis could be the 
factors involved in the stiffness/ elasticity of thyroid nodules.  
Stiffness did not correlate with cell number, while it was inversely correlated with the 
microvessel density, and positively associated with fibrosis. A similar cell number in benign 
adenomas compared to papillary thyroid cancer is not surprising given that both lesions show 
histological features with high cellularity and low colloid content. On the other hand, the 
inverse relationship with the microvessel density was unexpected. Indeed, malignant lesions 
are supposedly characterized by high vascularization. The number of vessels, but not the area 
of vascular surface, was found to be higher in benign lesions compared to carcinoma (31). On 
the other hand, tumor microvessel density has been reported to be directly associated with 
recurrence in differentiated thyroid cancer (32). Proietti at al. found that follicular adenomas 
had more extensive intratumoral hemorrhage and peripheral vascularization (33). Results 



























































































































































































































































































































































































































obtained by in vivo determination of vascularization with color Doppler US (2,3) are 
contradictory and not suggestive for a difference between benign and malignant thyroid 
nodules (34). Our results suggest that malignant nodules are characterized by a higher 
fibrosis/microvessel density ratio as compared to benign lesions. 
The activation of the fibrotic process has been described in cancers occurring in several 
tissues and in thyroid cancers as well (35,36). The development of fibrosis is related to a 
aberrant activation of myofibroblasts that play a crucial role in tumor progression (38). In 
several tissues, an increased risk of cancer progression has been linked to the stromal 
collagen content. Several factors are involved in this process, including transforming growth 
factors, which induce differentiation of fibroblasts to myofibroblasts (38). In the present 
study, the degree of fibrosis was strictly correlated with the stiffness at US elastography. In 
addition, both stiffness and fibrosis were correlated with malignancy. Therefore, these results 
highlight that the higher expression of fibrosis in thyroid cancer is the link between 
malignancy and stiffness on US elastography, as well as hardness on physical examination 
(1,3).  
After the finding of the role of fibrosis, evaluated by histology, we investigated the 
correlation between stiffness and some molecules involved in fibrosis and in the processes of 
cell-to-cell and cell-to-matrix adhesion. Low elasticity was correlated with a high expression 
of Gal-3 and FN-1. In several studies, an increased expression of Gal-3 has been related to 
malignant transformation, tumor progression and metastasis (21-24). In addition, Gal-3 has 
been proposed as a thyroid tumor marker, because its expression has been found to be 
increased in fine needle aspiration material as well as in histological samples of thyroid 
carcinomas (22,25). FN-1, an extracellular matrix protein produced by fibroblasts, has been 



























































































































































































































































































































































































































associated with malignancy (35-37) in several tissues. A high expression of FN-1 in thyroid 
carcinomas has been reported by several, but not all series (38-40). FN-1 is also expressed in 
fibrous tissue and basement membrane of goiters (37). In our series of thyroid nodules, a high 
expression of both Gal-3 and FN-1 was associated with fibrosis and malignancy. 
Interestingly, the NPV for nodule stiffness of the low expression of both Gal-3 and FN-1 was 
higher than the PPV of high expression of both molecules, in agreement with the observation 
that the NPV for malignancy is much higher than its PPV of high expression of both 
molecules (9). 
In summary, our data indicate that, compared to benign nodules, thyroid carcinomas have a 
similar number of cells, lower microvessel density and higher degree of fibrosis. When we 
examined the results obtained in nodules grouped according to the histological subtype, we 
observed that the microvessel density was lower in the classic variant, intermediate in the 
follicular variant of papillary carcinomas, and higher in follicular adenomas. In contrast, the 
degree of fibrosis, as well the expression of Gal-3 and FN-1 were the highest in the classic 
variant, intermediate in the follicular variant, and lowest in the follicular adenomas.  
In conclusion, our results confirm that nodule stiffness on US elastography is highly 
indicative of malignancy and show that real time qualitative elastography correlates well with 
quantitative elastography. We have also shown with a morphological approach that stiffness 
in thyroid nodules is inversely correlated with the microvessel density and directly correlated 
with fibrosis. Higher expression of molecules involved in the processes of fibrosis and cell-
to-cell and cell-to-matrix adhesion such as Gal-3 and FN-1 are related to nodule stiffness and 
malignancy. These features characterize the classic variant vs the follicular variant of 



























































































































































































































































































































































































































papillary thyroid carcinoma. More studies are needed to better understand the processes that 
cause stiffness in thyroid cancer 
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Legend of Figures 
 
FIG. 1 Elasticity of thyroid nodule in relation to the final histology of benign lesion (BN) or 
carcinoma (CA). HiEl: open square (    ); LoEl: closed square (    ) 
 
 




























































































































































































































































































































































































































FIG. 2.ROC curve describing  sensitivity and specificity of quantitative USE. The elastic ratio (ER) 
was 1.90 (1.18-2.77) (median and IQR) in 14 nodules with LoEl and 1.01-(0.91-1.10) in 10 nodules 
with HiEl (p=0.002). The ER cut-off of 1.1 identified carcinomas with a sensitivity of 86 % (12/14) 
and benign nodules with a specificity of 90% (9/10), with a negative predictive value of 82% and a 







































































































































































































































































































































































































































































































































Classic variant of  papillary carcinoma (CVPC), follicular variant (FVPC), tall cell  variant (TCPC); 
minimally invasive follicular carcinoma (MIFC); follicular adenoma (FA), hyperplastic  




















































































































































































































































































































































































































































TABLE 2. Elasticity at US elastography in relationship with cellularity, microvessel density, 












Cell number /field 









Microvessel density (μm2/field) 









Degree of fibrosis (%)   
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*NPV 95.9%;     PPV: 94.8 % 




















































































































































































































































































































































































































































TABLE 3. Histological diagnosis of  benign nodule (BN) or carcinoma (CA) in relationship 












Cell number /field 








Microvessel density (μm2/field) 








Degree of fibrosis (%)   
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Benign Nodule (BN); Carcinoma (CA) 
 
*NPV 97.8%;     PPV: 55.8 % 


















































































































































































































































































































































































































































TABLE 4. Elasticity at US elastography,  cellularity, microvessel density and fibrosis in classic and 





FAPC (N= 37) 
 
FVPC (N= 25) 
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    1.16    (n=3) 
 
   1.50 (n=6) 
 




Cell number /field 
















  115.5 (92.4-2004) 
 




Degree of fibrosis (%)   












  0.01 
 
Gal-3 
           High 
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Follicular adenoma (FA), follicular variant of Papillary carcinoma (FVPC), classic variant of  Papillary 
carcinoma (CVPC);  
*ER was measured in a total number of 16 nodules of this subgroup. The number of nodule in each 
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